Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 2Unknown 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 1

Conditions

Breast Neoplasms 6Motor Activity 4Stomach Neoplasms 3Rectal Neoplasms 3Neoplasms 3Pain, Postoperative 2Lung Neoplasms 2Leukemia, Myeloid, Acute 2Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Cognitive Complications 1Peritoneal Neoplasms 1Pediatric Brain Tumor 1Pathologic Processes 1Papillomavirus Infections 1Neuroendocrine Tumors 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Lymphedema 1Lymphatic Metastasis 1Liver Diseases 1Keratosis, Actinic 1Infections 1Gastrostomy 1Fatigue 1Epstein-Barr Virus Infections 1Endometrial Neoplasms 1Emergence Delirium 1

Interventions

venetoclax 124Azacitidine 96Cytarabine 71fludarabine 44Specimen Handling 38Cyclophosphamide 38Daunorubicin 27Decitabine 26Biopsy 25Idarubicin 24Granulocyte Colony-Stimulating Factor 21gilteritinib 18Injections 18fludarabine phosphate 17Whole-Body Irradiation 17Melphalan 16Busulfan 16Stem Cell Transplantation 15Mycophenolic Acid 15ivosidenib 13Cladribine 13decitabine and cedazuridine drug combination 12Gemtuzumab 12Tacrolimus 11CPX-351 11X-Rays 10Filgrastim 10revumenib 9enasidenib 9Cyclosporine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Myeloid, Acute × Control Groups × Clear all
NCT06816134 2026-04-23

Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia

The First Affiliated Hospital of Soochow University

Phase 2 Recruiting
48 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06301425 2024-07-10

MRD Response-adapted Allo-HSCT for Adverse-risk AML

Peking University People's Hospital

Phase NA Recruiting
178 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡